Fluocinolone Acetonide Oil
Product Images NDC 71335-2879

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fluocinolone Acetonide (NDC 71335-2879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352879 Extendedlabel)

Extended Label (713352879 Extendedlabel)
This text provides guidance on the dosage and administration of Fluocinolone acetonide oil, 0.01% (ear drops) for the treatment of chronic eczematous external otitis. It explains how to apply the drops using the supplied ear-dropper, including the number of drops, positioning of the head, and duration for which the head should be tilted. It also instructs to gently pat excess material dripping out of the ear with a clean cotton ball and suggests following the instructions twice daily for 7-14 days. Additionally, there is guidance on discarding the unused portion after 2 months from the date of first opening.*
FDA Label Image

Structure (Fluocinolone Acetonide Otic Structure)

FDA Label Image

Label (Lbl713352879)

Label (Lbl713352879)
This is a description of Fluocinolone Acetonide Ear Drops. Each bottle contains 0.01% of the active ingredient Fluocinolone Acetonide USP. The inactive ingredients include Isopropyl Alcohol USP, Refined Peanut Oil NF, Light Mineral Oil NF, Isopropyl Myristate NF, and Oleth-2. The package contains 20 mL in a 1 oz bottle with a dropper for otic use only. Storage instructions advise keeping the bottle tightly closed at temperatures between 20°C-25°C (68°F-77°F), with excursions permitted to 15°C-30°C (59°F-86°F). The product is labeled for use by Bryant Ranch Prepack, Inc. Quagen Pharmaceuticals and should be discarded 2 months after initial use to be kept out of reach of children. Prescribing information can be accessed through scanning the package insert QR code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.